Lieff Cabraser Civil Justice Blog
Kathrine Benson Discusses Shareholder Derivative Actions at Institutional Investors 2020 Fall Conference

Katherine Benson Discusses Shareholder Derivative Actions at Institutional Investors 2020 Fall Conference

Lieff Cabraser partner Katherine Lubin Benson recently joined a virtual roundtable discussion on “Shareholder Derivative Actions as a Tool To Improve Corporate Governance” as a part of the Council of Institutional Investors 2020 Fall Conference: Corporate Governance in the Wake of Covid-19.

The full panelist list was:

  • Esther Aguilera, President and CEO, Latino Corporate Directors Association
  • Robert Bartlett, Michael Heyman Professor of Law, Faculty Director, Berkeley Center for Law, Business, and the Economy
  • Katherine L. Benson, Partner, Lieff Cabraser, Heimann & Bernstein, San Francisco, CA
  • Tracy Stewart, Corporate Governance Manager, Florida State Board of Administration

About Katherine Lubin Benson

A partner in Lieff Cabraser’s San Francisco office, Katherine Lubin Benson specializes in securities and derivative suits and antitrust class actions. She was one of the firm’s attorneys heading the shareholder derivative action against Wells Fargo’s current and former officers and directors arising from the bank’s massive illicit sales practices scandal. Katherine was a key member of Lieff Cabraser team representing Co-Lead Plaintiff Fire and Police Pension Association of Colorado in the action, which settled for a $240 million cash payment and corporate governance reforms in late 2018. The settlement received final approval in April 2020, and represents the largest insurer-funded derivative settlement in history.

Katherine served as Class Counsel representing a class of hospitals, third-party payors, and uninsured persons in 29 states and the District of Columbia in an antitrust action against defendants Momenta Pharmaceuticals, Inc. and Sandoz Inc. for their alleged monopolization of enoxaparin, the generic version of the anti-coagulant blood clotting drug Lovenox. The case resulted in a nationwide settlement totaling $120 million, making it the second largest indirect purchaser antitrust pharmaceutical settlement fund in history.

Katherine was recently named as one of six lawyer representatives to the Ninth Circuit Judicial Counsel for the 2020-2023 term, and currently serves on the Board of Directors of the Northern District Practice Program, which provides continuing legal education programing for judges and practitioners in the district. She also serves on the Board of Directors of the East Bay Community Law Center, a non-profit affiliated with Berkeley Law providing free legal services to low-income communities.